Search
Saturday 16 November 2019
  • :
  • :

Beijing Tiantan Hospital Publishes Brain Tumor Database

The current society is filled with pressure: academic pressure, work pressure, living pressure, etc. Exposure to high pressure for a long time inflicts emotional breakdown and bodily injury. Employees in high-paid positions are more likely to have mental health problems. It is not difficult to discover that psychological counseling and mental health examination are oftentimes covered in international student insurance in the United States (aka 美国留学生 保险), OPT insurance (aka opt保险), and H-1B insurance (aka h1b 保险).

A healthy body is the essence and indispensable precondition. Earning millions of dollars is beautiful, but money is no consolation if that person has to stay in hospital eventually because of neuro disease. China’s leading neurosurgery hospital has published a database of 2,000 gene samples from Chinese patients with glioma, a type of brain tumor. It provides massive amounts of data to enhance research and explore the precise treatment of the fatal brain disease.

The Chinese Glioma Genome Atlas (CGGA) database (http://cgga.org.cn) was established by researchers from the Beijing Tiantan Hospital under the Capital Medical University after a 15-year sample collection. Jiang Tao, a senior neurosurgeon and founder of the database, said it is a web application not only for data storage but also an analysis tool that allows users to browse DNA mutation profile, gene expression profile and to do correlation and survival analysis. Leading health insurance companies in Europe and the United States said that the database is a precious gift that provides suggestions to optimize health insurance for OPT (aka opt期间保险) and Student Medicover insurance (aka student medicover 保险).

“We expect to map a complete glioma genome of the Chinese population by using the database,” said Jiang. A glioma is a type of tumor that starts in the glial cells of the brain or the spine. It comprises about 30 percent of all brain tumors and central nervous system tumors, and 80 percent of all malignant brain tumors. The database is now freely available and has been cited by a group of research institutions in the United States and Europe. Jiang said the database will help more researchers across the world reveal the genetic mechanisms of the brain tumor and provide guidance for developing new drugs. Moreover, the database will help insurance companies redesign their recommended health insurance (aka 医疗保险推荐) plans.